AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guéant-Rodriguez, R.-M.
Right arrow Articles by Mutchinick, O. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guéant-Rodriguez, R.-M.
Right arrow Articles by Mutchinick, O. M
Agricola
Right arrow Articles by Guéant-Rodriguez, R.-M.
Right arrow Articles by Mutchinick, O. M
American Journal of Clinical Nutrition, Vol. 83, No. 3, 701-707, March 2006
© 2006 American Society for Nutrition

ORIGINAL RESEARCH COMMUNICATION

Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations1,2,3

Rosa-Maria Guéant-Rodriguez, Jean-Louis Guéant, Renée Debard, Sylvie Thirion, Lu Xiao Hong, Jean-Pierre Bronowicki, Farès Namour, Nicodème W Chabi, Ambaliou Sanni, Guido Anello, Paolo Bosco, Corrado Romano, Emile Amouzou, Heidy R Arrieta, Beatríz E Sánchez, Antonino Romano, Bernard Herbeth, Jean-Claude Guilland and Osvaldo M Mutchinick

1 From INSERM U-724, Cellular and Molecular Pathology in Nutrition, Faculté de Médecine, University Henry Poincaré of Nancy, Vandoeuvre lès Nancy, France (R-MG-R, J-LG, RD, ST, LXH, J-PB, and FN); the Laboratory of Biochemistry and Nutrition, Lomé, Togo (NWC and AS); the IRCCS, Oasi Maria SS–Institute for Research on Mental Retardation, Troina, Italy (GA, PB, and CR); the Laboratory of Biochemistry and Molecular Biology, University of Cotonou, Cotonou, Bénin (EA); the Department of Genetics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico(HRA, BES, and OMM); the Department of Internal Medicine and Geriatrics, Universitá Cattolica del Sacro Cuore, Complesso Integrato Columbus, Rome, Italy (AR); the Preventive Health Care Center and INSERM U525, Nancy, France (BH); and the Department of Physiology and Nutrition, University of Burgundy, Dijon, France (J-CG)

2 Supported by grants from the Conseil Régional de Lorraine, the Fondation de France, the Institut National de la Santé et de la Recherche Médicale, the Ministère de la Recherche et de la Technologie, and the Consejo Nacional de Ciencia y Tecnología (CONACYT - M0237) México.

3 Address reprint requests and correspondence to J-L Guéant, INSERM U-724, Faculté de Médecine, Université Henri Poincaré, BP 184, 54500, Vandoeuvre lés Nancy, France. E-mail: Jean-Louis.Gueant{at}medecine.uhp-nancy.fr.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Methylenetetrahydrofolate reductase (MTHFR) 677C->T polymorphism is heterogeneously distributed worldwide, with the highest and lowest frequencies of the T allele in Mexico and Africa, respectively, and a south-to-north gradient in Europe. Distribution of MTHFR 1298A->C is less well known. It has been hypothesized that 677T frequency could result in part from gene-nutrient interactions.

Objective: The objective was to compare the association of 677T and 1298C alleles with plasma concentrations of homocysteine, folate, and vitamin B-12 in geographical areas with contrasting 677T allele frequencies.

Design: Healthy young adults (n = 1277) were recruited in Mexico City, the West African countries of Bénin and Togo, France, and Sicily (Italy). Homocysteine, folate, and vitamin B-12 were measured in plasma, and MTHFR polymorphisms were measured in genomic DNA.

Results: Mexico City and Sicily reported the highest and Bénin and Togo reported the lowest plasma concentrations of folate. Mexico City had the highest 677T allele prevalence and the lowest influence of 677TT genotype on homocysteine, whereas the opposite was observed in Africa. The prevalence of the 1298C allele was lowest in the Mexicans and Africans and highest in the French. The percentage of the 677T genotype was significantly associated with the folate concentrations in 677CC carriers in a univariate analysis (R = 0.976; 95% CI: 0.797, 0.996; P < 0.0002) and in a multiple regression model that included homocysteine, vitamin B-12, and age (P = 0.0002).

Conclusion: Our data agree with the hypothesis of a gene-nutrient interaction between MTHFR 677C->T polymorphism and folate status that may confer a selective advantage of TT-homozygous genotype when dietary intake of folate is adequate, at least in the areas studied.

Key Words: Methylenetetrahydrofolate reductase • polymorphism • folate • homocysteine • vitamin B-12


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Homocysteine is a non-protein-forming sulfur amino acid of one carbon metabolism that results from the demethylation of S-adenosylmethionine. Plasma concentrations of total homocysteine (tHcy) are influenced by nutritional predictors that includefolate and vitamin B-12 and by polymorphisms of methylenetetrahydrofolate reductase [(MTHFR) MTHFR 677C->T and 1298A->C] (1, 2). MTHFR catalyzes the synthesis of 5-methyltetrahydrofolate, the methyl donor for the vitamin B-12–dependent remethylation of homocysteine to methionine. The 677TT genotype, which leads to a substitution of an alanine residue for a valine residue in the amino acid consensus sequence, encodes for a thermolabile variant that reduces enzyme activity by 70% and increases tHcy, at least in the case of low dietary folate (1-3). Consequently, the 677C->T polymorphism is a key genetic predictor of 2 major functions of the one-carbon metabolism, DNA synthesis and DNA methylation, whose effects are modulated by folate status (4). Double 677CT/1298AC heterozygosity was found to be associated with moderate hyperhomocysteinemia, particularly in persons with low blood folate concentrations (5).

It may be that the MTHFR 677C->T polymorphism was produced by a single ancestral mutation, because it is strongly associated with a common haplotype of the gene (6). Its worldwide distribution is very heterogeneous: the highest and thelowest T allele prevalences are reported in Mexico and sub-Saharan Africa, respectively (7–12). A north-to-south gradient of allele 677T prevalence has been observed in Western Europe, and the highest frequency occurs in Sicily (13). The mechanisms generating this gradient are not known and could involve, at least in part, gene-nutrient interactions. Folate intake is lower in the diet of Northern Europe than in that of Mediterranean countries (14–18). It was therefore hypothesized that dietary folate is one of the factors that has influenced the prevalence of T allele in Europe (1). Indeed, the T allele is associated with a greater risk of genetic birth defects, but that risk seems to be neutralized by a diet rich in folate (14). Two studies evaluated the worldwide distribution of the T allele, one in adults (11) and the other in newborns (12). However, the efforts to test the validity of the above hypothesis have not included evaluation of the respective relation of the allele with homocysteine and its 2 main nutritional predictors, folate and vitamin B-12, in geographical areas with contrasting 677T allele frequencies. In the current study, we examined the distribution of allele frequencies of the 2 polymorphisms of MTHFR in a country with a high 677T allele frequency (Mexico), 2 countries with an intermediate frequency [Italy (Sicily) and France], and 2 countries with a low frequency (Benin and Togo), and we evaluated the association of these distributions with folate and 2 other markers of homocysteine metabolism, tHcy and vitamin B-12.


   SUBJECTS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Recruitment of subjects
The study was carried out in a population sample of 1277 healthy persons. All subjects were examined medically before inclusion and recruited on the basis of absence of any known disease. Particular attention was given to the absence of reported cancer; of cardiovascular, renal, hepatic, or genetic disease; and of vitamin supplementation. The 300 volunteers from Mexico were blood donors at the National Institute of Medical Sciences and Nutrition in Mexico City. The 146 volunteers from Sicily were from the rural area around the village of Troina in the northeastern part of Sicily, and they attended the medical center in Troina for preventive care. The 366 apparently healthy volunteers from France were recruited either in the northeast (Lorraine) or east (Burgundy and Franche Comté). A total of 195 volunteers was recruited in Togo, including 127 volunteers from the coast (Lomé) and 68 from the interior savanna. The 270 volunteers from Benin were recruited in the coastal city of Cotonou. Part of the African population was described previously (8).

Written informed consent was obtained from subjects. Institutional review board approval was obtained from the ethics committees of the National Institute of Medical Sciences and Nutrition (Mexico City, Mexico), the medical center of Troina [IRCCS Associazione Oasi Maria SS, Troina (Sicily), Italy], the University Hospital Center of Nancy (Nancy, France), the University of Bénin (Lomé, Togo), and the University of Cotonou (Cotonou, Bénin).

Biological and genetic analyses
All specimens were tested in a single laboratory (Nancy, France). Fasting venous blood was collected in EDTA-containing tubes and, after immediate centrifugation, aliquots were stored at –70 °C until analysis. Plasma tHcy concentrations (protein-bound and free homocysteine) were determined by using the fluorescence polarization immunoassay (FPIA IMx-homocysteine method; Abbott Laboratories Diagnostics Division, Abbott Park, IL). Plasma vitamin B-12 and folate concentrations were assayed by using a VB12 and Folates immunoassay kit on an ACS 180 automated chemiluminescent system (both: Bayer Health Care Diagnostics, Cergy Pontoise, France) with threshold values established at 100 pmol/L and 7 nmol/L, respectively, according to World Health Organization criteria (1). Buffy coat was prepared from the previously collected blood, and genomic DNA was isolated with the use of a kit according to the manufacturer's recommendations (Qiagen-France, Courtaboeuf, France). A polymerase chain reaction–based RFLP method was used to determine the genotypes of MTHFR, as described previously (3, 5, 13). The 677C->T polymorphism creates a Hinf I recognition site in a 198-bp amplified DNA fragment that was used to differentiate the various genotypes: 677CC, 677CT, and 677TT. The MTHFR 1298A->C polymorphism was analyzed by using a previously described protocol (13). The enzyme Fnu4HI cuts the amplified DNA of C allele carriers. Electrophoresis with 15% polyacrylamide gel showed a single 138-bp fragment for the 1298AA homozygotes, two 119- and 19-bp fragments for the 1298CC homozygotes, and three 138-, 119-, and 19-bp fragments for the 1298AC heterozygotes.

Statistical analysis
Allele and genotype frequencies were reported as percentages and 95% CIs. A continuity-corrected chi-square test and Bonferroni adjustment were used to assess differences between groups. Continuous variables were reported as medians and 25th and 75th percentiles. A Student's t test for unpaired data and Bonferroni adjustment were used to compare continuous variables. In the case of skewed data distributions, logarithmic transformations were carried out to normalize the distributions. Univariate regression analyses were performed by transformed correlation (Fisher z transformation) and stepwise multiple regressions with models that included age, tHcy, vitamin B-12, and folate. A P value ≤ 0.05 was considered significant. Data were analyzed by using STATVIEW for WINDOWS software (version 5.0.0.0; SAS Institute Inc, Berkeley, CA) and EPIINFO for MS-DOS software (version 6.0; World Health Organization, Geneva, Switzerland).


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
As expected, the highest and lowest frequencies of the 677T allele and the 677TT genotype were observed in Mexico and West Africa, respectively (Table 1Go). The T allele was also significantly more frequent in Sicily than in France (Table 1Go). We found no significant difference in T allele frequency [36.1% (95% CI: 28.7%, 44.2%) and 36.0% (31.2%, 40.8%); P = 0.6725] or 677TT genotype [13.9% (7.8%, 23.8%) and 14.3% (9.9%, 19.8%); P = 0.9262] between the subsets of the French population from the northeastern and eastern parts of France, respectively. West African countries and Mexico were the 2 areas with the lowest frequencies of the 1298C allele and the 1298CC genotype, and the highest frequency was reported in France (Table 1Go). The distributions of the 3 genotypes of MTHFR 677C->T and 1298A->C polymorphisms observed in the 7 areas of recruitment did not differ significantly from those expected under Hardy-Weinberg equilibrium (data not showed).


View this table:
[in this window]
[in a new window]
  		TABLE 1 Distribution of methylenetetrahydrofolate reductase 677C->T and 1298A->C polymorphisms in 1277 subjects from France, Italy, West Africa, and Mexico1

 
The plasma concentrations of tHcy, folate, and vitamin B-12 are shown in Table 2Go. Mexico had the highest folate concentration, and the concentration did not differ significantly between France and Sicily. The highest concentrations of tHcy and the lowest concentrations of folate were registered in West African countries. The highest rate of folate deficiency was recorded in Togo, and the lowest rate was recorded in Mexico, when a threshold of 7 nmol/L is used (7; Table 2Go). In contrast, a low vitamin B-12 concentration (<100 pmol/L) was reported in 9.7% of the subjects from Mexico; this rate was significantly higher than that in subjects from France, Italy, and the African countries. Within Europe, tHcy and vitamin B-12 concentrations were significantly lower and higher, respectively, in Italy than in France (Table 2Go). In multiple regression analysis, folate was a significant independent predictor of tHcy in all of the areas, and tHcy was also associated with vitamin B-12 in Sicilians and Mexicans (Table 3Go). The TT genotype was associated with a dramatically higher concentration of tHcy in West Africans. It produced a mild but significant elevation of tHcy in France and Italy and no effect in Mexico (Figure 1Go). In contrast, the 677CT/1298AC double heterozygosity did not have a significantly greater effect on total homocysteine than did the 677CT/1298AA genotype [10.0 (7.9, 12.2) µmol/L and 10.0 (8.1, 14.0) µmol/L, respectively; P = 0.0952]. This finding was confirmed when the analysis was stratified by area.


View this table:
[in this window]
[in a new window]
  		TABLE 2 Plasma concentrations of homocysteine, folate, and vitamin B-12 in 1180 subjects from France, Italy, West Africa, and Mexico1

 

View this table:
[in this window]
[in a new window]
  		TABLE 3 Backward stepwise multiple regression analysis of the predictors of plasma concentrations of homocysteine in populations from West Africa, France, Italy, and Mexico1

 

Figure 1
View larger version (27K):
[in this window]
[in a new window]
  		FIGURE 1. Homocysteine plasma concentrations (µmol/L; box plots represent medians, interquartiles, and range) according to the genotypes of methylenetetrahydrofolate reductase 677C->T in West Africa (n = 368), Italy (n = 146), France (n = 366), and Mexico (n = 300). Student's t test for unpaired data and Bonferroni adjustment were used to compare the log-transformed total homocysteine of CC, CT, and TT genotypes within countries; boxes with different superscript letters were significantly different, P < 0.005.

 
We investigated whether the 677T allele frequency was associated with folate status and other predictors of homocysteine metabolism in the 7 areas (Table 4Go). In univariate analysis, we found a correlation between the T allele frequency and, in order of significance, the median folate, tHcy, and vitamin B-12 concentrations reported in the 7 areas. The association of the T allele frequency with folate remained significant when the folate concentration of 677CC carriers was considered (Table 4Go). To avoid bias due to the effect of TT genotype on folate concentration, we considered the folate concentration only in 677CC homozygotes. A close inverse correlation was also found between 677T allele frequency and the percentage of subjects with low plasma folate (<7 nmol/L) (Figure 2Go). Folate in 677CC carriers and, to a lesser extent, tHcy were the 2 residual significant predictors of T allele frequency in a stepwise multivariate regression analysis that also included age and vitamin B-12 (Table 4Go). The same results were obtained when the association of folate concentration in 677CC carriers with the frequency of TT genotype was considered (Table 4Go). In contrast, there was no significant association between the frequency of the combined 677CT/1298AC genotype and plasma folate in 677CC carriers (P = 0.2450).


View this table:
[in this window]
[in a new window]
  		TABLE 4 Predictors of the frequency of MTHFR 677T allele and 677TT genotype among 7 areas of West Africa, France, Italy, and Mexico in univariate and backward stepwise multiple regression analyses1

 

Figure 2
View larger version (16K):
[in this window]
[in a new window]
  		FIGURE 2. Correlation of the frequency of methylenetetrahydrofolate reductase 677T allele (logarithm) with the percentage of subjects with folate deficiency (logarithm of the percentage of subjects with plasma folate < 7 nmol/L) in subjects from 7 areas (from right to left of the x axis): the coast (n = 68) and the savannah (n = 127) of Togo; the coast of Benin (n = 173); the northeastern (n = 131) and eastern (n = 235) regions of France; the island of Sicily (n = 146); and Mexico City (n = 300). R = –0.940, 95% CI: –0.994, –0.539; P = 0.0027. Dotted lines represent the 95% CI.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
The current study was performed on a population sample of reproductive age, which avoided any influence of a possible association of 677C->T and 1298A->C genetic polymorphisms with a risk of decreased longevity (19). As expected, the T allele frequency was highest in Mexico City, intermediate in eastern France and Sicily, and lowest in West Africa. The frequencies of the 677TT genotype and the 677T allele observed in Mexican and Sicilian newborns in a study by Wilcken et al (11) did not differ significantly from those we observed in young adults in Mexico (P = 0.6429) and Sicily (P = 0.5619). In the current study, such frequencies in newborns also did not differ significantly from those Wilcken et al (11) found or from the frequencies in young adults in northeastern France (P = 0.9318). Assuming that a very long-term change in the nutritional environment may influence 677T and 1298C allele frequencies in migrants, we found it interesting to compare the allele frequencies in young adults with those published in newborns in corresponding migrant populations (11). We reported a 677T allele frequency in Benin and Togo that was significantly lower than that in black newborns in Atlanta, GA [9.0% (95% CI: 7.1%, 11.2%) and 13.9% (11.2%, 17.1%), respectively; P = 0.0269] (Table 1Go; 8, 11). The 677T allele in Hispanic newborns in Atlanta (41.1%; 95% CI: 32.8%, 49.8%) was also significantly less frequent than that reported in the young adults in our population (P = 0.0006; Table 1Go) and newborns [57.0% (95% CI: 53.9%, 60.0%); P = 0.0008] in another study in Mexico (11). These differences in allele frequency between migrant and settled populations may derive from differences in the study design or the age of the subjects studied, or from partial ethnic mixing. However, the influence of a change in gene pressure on the nutritional environment should be also considered.

Population genetic studies are one way to highlight geographical and ethnic differences that suggest evolutionary pressures generated by environmental factors. Such possible pressures on the nutritional environment remain speculative in the case of MTHFR polymorphisms. We evaluated the influence of the nutritional environment on ethnic differences in MTHFR variants by comparing populations that have different T allele frequencies and distinct traditional diets. Our results showed that the highest T allele frequency was in the area where influence of the 677TT genotype on tHcy was the lowest (Figure 1Go and Table 1Go), whereas the lowest frequency was registered in Africa, where the genotype influence on tHcy was the most evident. For example, a high tHcy concentration was observed in the 4 patients in Africa with a 677TT genotype, and all of these patients had a low plasma concentration of folate and no other known genetic, metabolic, or nutritional characteristic that influenced tHcy.

In all 7 of the areas studied, we observed a close correlation of the T allele frequency with both the plasma concentration of folate and the percentage of persons with low plasma folate (Figure 2Go). Because we excluded the subjects who recurrently used vitamin supplements, the plasma folate concentration of 677CC carriers can be considered a biological marker of short-term dietary folate intake. However, a limitation of the current study was that we could not consider the long-term effect of folate status on T allele frequency. Despite limited ethnic commonalities in these areas, the highest concentration of folate and the lowest rate of folate deficiency were recorded in the 2 areas, Mexico City and Sicily, that had the highest T allele frequency. In fact, the main similarity between those 2 populations is their typical diet, which is poorer in animal proteins than the so-called Western diet but much richer in wheat, corn, beans, lentils, and fresh fruit and vegetables (17, 18, 20). Therefore, it would be particularly interesting to compare the 2 diets to estimate the dietary intake and bioavailability of folate and other nutrients with respect to homocysteine metabolism. Several estimates in reference samples of European populations showed south-to-north decreasing gradients of dietary folate intake and of T allele frequency. For example, dietary folate was estimated at 190 µg/d in females in Netherlands, 268.2 ± 91.5 µg/d in females in northeastern or eastern France, and 323 ± 87 µg/d in nonelderly females in central Italy (14, 15, 17). The high prevalence of folate deficiency in West Africa may be involved in the evident phenotypic effect of T allele on tHcy, which showed interaction between the environment and genetic pressure (8). Indeed, up to 26.4% of the African population in the current study had a plasma folate concentration below the 7 nmol/L threshold, whereas only 2.0% of the Mexico City population did so (Table 2Go). However, 9.7% of the Mexican group had a vitamin B-12 concentration of <100 pmol/L, which confirmed the high rate of vitamin B-12 deficiency reported in a recent review of vitamin B status in the Americas (Table 2Go; 21). In addition, vitamin B-12 was a predictor of tHcy in the 2 populations with the highest folate status, ie, Sicilians and Mexicans (Table 2Go), as previously reported in subjects supplemented with folate (22).

The current study showed a high frequency of MTHFR 677TT in the presence of a high concentration of folate and a low frequency in the presence of low folate concentrations, but it could not ascertain whether MTHFR is an ancestral mutation. Rosenberg et al (6) showed that the MTHFR 677T variant has occurred on a common haplotype in Israelis, Japanese, and Ghanaians. They (6) and others (23) suggested that MTHFR TT homozygosity may confer a survival advantage in populations with adequate dietary folate consumption. Our data are in accord with this hypothesis. All of the subjects in the current study were healthy young adults, and thus the differences in T allele frequency may be related to a long-term influence of diet on birth defects rather than on pathologic conditions that occur late in life. However, the association of MTHFR mutations with the viability of embryo or fetus may be difficult to estimate, because most spontaneous abortions occur before pregnancy is diagnosed. A study found a survival advantage related to MTHFR 677TT, with a frequency in newborns 4-fold that in aborted fetuses (24). In contrast, an increased frequency of both 677T and 1298C mutated alleles has been reported in a series of spontaneously aborted embryos (25). Increased tHcy and related genetic predictors have also been implicated as risk factors for neural tube defects, Down syndrome, trisomy 18, and recurrent embryo losses (26–31), and these associations seem to be influenced by the geographical location and nutritional status of the subjects (30–32). For both neural tube defects and Down syndrome, MTHFR polymorphisms are risk factors in northern Europe, with its low-folate diet and low 677T allele frequency, but are neutral in western and southwestern Europe, where both dietary folate intake and T allele frequency are much higher (25, 26, 30–47). The risk of birth defects may be associated with other predictors of homocysteine metabolism interacting with MTHFR and folate. For example, the presence of transcobalamin (TCN) 776G allele and gene-gene interaction between MTHFR 677TT and TCN 776G allele have been found to increase the risk of spontaneous abortion in Greece (48, 49). TCN 776C->G is a gene polymorphism influencing the expression of transcobalamin, the protein responsible for cell delivery of vitamin B-12 (50). The benefit deriving from a high dietary intake of folate by 677T allele carriers may be due to various mechanisms, such as the increased synthesis of purines and pyrimidines needed for DNA replication (2, 51). In addition, folate may neutralize the adverse cellular effects of the reduced activity of the thermolabile MTHFR variant, such as the defective remethylation of homocysteine, the subsequent DNA hypomethylation, and the uracile misincorporation (52). It may also influence epigenetic mechanisms regulating gene expression (53).

In 2 previous studies (54, 55), the 1298A->C polymorphism in combination with 677C->T appeared to affect enzyme activity and tHcy. However, the current study, as well as others (56–60)—including a biochemical study of the recombinant variants of MTHFR (60)—failed to find any association of the 677CT/1298AC combined genotype with tHcy. Finally, we also failed to find any influence of folate on the distribution of this genotype in the 7 areas studied.

In conclusion, comparing populations that have greatly differing allele 677T frequencies and folate status, we showed an association of 677T allele frequency with both the folate plasma concentration and the percentage of folate deficiency in 7 areas on 3 continents. This observation supports the hypothesis of gene-nutrient interaction between MTHFR and folate status.


   ACKNOWLEDGMENTS
 
R-MG-R and J-LG contributed equally to the conception and design of the study, statistical analysis and data interpretation, and manuscript redaction. RD, ST, LXH, NWC, EA, GA, PB, HRA, and BES were responsible for the sampling, genotyping, and biological analyses. J-PB, FN, AS, EA, CR, AR, BH, and J-CG were responsible for local coordination of the study and recruitment of subjects in all areas except Mexico. OMM was responsible for local coordination of the study and recruitment of subjects in Mexico, for data interpretation, and for manuscript revision. J-LG was responsible for the general coordination of the study. None of the authors had any personal or financial conflict of interest.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Bollander-Gouaille C. Focus on homocysteine and the vitamins involved in its metabolism. 2nd ed. Paris, France: Springer-Verlag, 2002.
  2. Ueland PM, Hustad S, Schneede J, et al. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001;22:195-201.[Medline]
  3. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.[Medline]
  4. Friso S, Choi SW, Girelli D, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction in the folate status. Proc Natl Acad Sci U S A 2002;99:5606-11.[Abstract/Free Full Text]
  5. van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044-51.[Medline]
  6. Rosenberg N, Murata M, Ikeda Y, et al. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet 2002;70:758-62.[Medline]
  7. Mutchinick OM, Lopez MA, Luna L, Waxman J, Babinsky VE. High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metabol 1999;68:461-7.[Medline]
  8. Amouzou EK, Chabi NW, Adjalla CE, et al. High prevalence of hyperhomocysteinemia related to folate deficiency and the 677C->T mutation of the gene encoding methylenetetrahydrofolate reductase in coastal West Africa. Am J Clin Nutr 2004;79:619-24.[Abstract/Free Full Text]
  9. Ubbink JB, Christianson A, Bester MJ, et al. Folate status, homocysteine metabolism, and methylene tetrahydrofolate reductase genotype in rural South African blacks with a history of pregnancy complicated by neural tube defects. Metabolism 1999;48:269-74.[Medline]
  10. Rajkovic A, Mahomed K, Rozen R, Malinow MR, King IB, Williams MA. Methylenetetrahydrofolate reductase 677 C->T polymorphism, plasma folate, vitamin B(12) concentrations, and risk of preeclampsia among black African women from Zimbabwe. Mol Genet Metabol 2000;69:33-9.[Medline]
  11. Wilcken B, Bamforth F, Li Z, et al. Geographical and ethnic variation of the 677C->T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 2003;40:619-25.[Free Full Text]
  12. Pepe G, Camacho Vanegas O, Giusti B, et al. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Am J Hum Genet 1998;63:917-20.[Medline]
  13. Bosco P, Guéant-Rodriguez RM, Anello G, et al. In Sicily, methionine synthase (MTR) 2756 (A->G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet 2003;121:219-24.
  14. Zetterberg H. Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol 2004;2:7.[Medline]
  15. de Bree A, Verschuren WM, Blom HJ, Kromhout D. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20–65 y. Am J Clin Nutr 2001;73:1027-33.[Abstract/Free Full Text]
  16. Mennen LI, de Courcy GP, Guilland JC, et al. Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr 2002;76:1279-89.[Abstract/Free Full Text]
  17. Kushi LH, Lenart EB, Willett WC: Health implications of Mediterranean diets in light of contemporary knowledge. 1. Plant foods and dairy products. Am J Clin Nutr 1995;61(suppl):1407S-15S.
  18. Turrini A, Saba A, Perrone D, Cialfa E, D'Amicis A. Food consumption patterns in Italy: the INN-CA Study 1994–1996. Eur J Clin Nutr 2001;55:571-88.[Medline]
  19. Panza F, D'Introno A, Colacicco AM, et al. Vascular genetic factors and human longevity. Mech Ageing Dev 2004;125:169-78.[Medline]
  20. Cavantes EI, Mutchinick OM. Defectos de cierre del tubo neural y nutrición materna: estudio multicéntrico en una muestra de la boblación Mexicana. (Neural tube defects and maternal nutrition. Multicentric study in a Mexican population.) Doctoral dissertation. National Autonomous University of Mexico, Mexico City, Mexico, 1999 (in Spanish).
  21. Allen LH. Folate and vitamin B12 status in the Americas. Nutr Rev 2004;62:S29-33.[Medline]
  22. Quinlivan EP, McPartlin J, McNulty H, et al. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet 2002;359:227-8.[Medline]
  23. Munoz-Moran E, Dieguez-Lucena JL, Fernandez-Arcas N, Peran-Mesa S, Reyes-Engel A. Genetic selection and folic acid intake during pregnancy. Lancet 1998;352:1120-1.[Medline]
  24. Isolato PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 2000;67:986-90.[Medline]
  25. Zetterberg H, Regland B, Palmér M, et al. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet 2002;10:113-8.[Medline]
  26. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1.[Medline]
  27. James SJ, Pogribna M, Pogribny IP, et al. Abnormal folate metabolism and methylenetetrahydrofolate reductase (MTHFR) gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 1999;70:495-501.[Abstract/Free Full Text]
  28. Nelen WL, Steegers EA, Eskes TK, Blom HJ. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet 1997;350:861 (letter).[Medline]
  29. Lissak A, Sharon A, Fruchter O, Kassel A, Sanderovitz J, Abramovici H. Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss. Am J Obstet Gynecol 1999;181:126-30.[Medline]
  30. Gueant JL, Candito M, Andres E, Van Obberghen E, Nicolas JP. Familial pernicious anaemia with hyperhomocysteinaemia in recurrent early pregnancy loss. Thromb Haemost 2004;92:1147-9.[Medline]
  31. Kumar KS, Govindaiah V, Naushad SE, Devi RR, Jyothy A. Plasma homocysteine levels correlated to interactions between folate status and methylene tetrahydrofolate reductase gene mutation in women with unexplained recurrent pregnancy loss. J Obstet Gynaecol 2003;23:55-8.[Medline]
  32. Guéant JL, Guéant-Rodriguez RM, Anello G, et al. Genetic determinants of folate and vitamin B12 metabolism: a common pathway in neural tube defect and Down syndrome? Clin Chem Lab Med 2003;41:1473-7.[Medline]
  33. de Franchis R, Sebastio G, Andria G, Mastroiacovo P. Spina bifida, 677TT mutation, and role of folate. Lancet 1995;346:1703 (letter).[Medline]
  34. Papapetrou C, Lynch SA, Burn J, Edwards YH. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 1996;348:58 (letter).[Medline]
  35. de Franchis R, Buoninconti A, Mandato C, et al. The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J Med Genet 1998;35:1009-13.[Abstract]
  36. Guéant-Rodriguez RM, Rendeli C, Namour B, et al. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects. Neurosci Lett 2003;344:189-92.[Medline]
  37. Stegman K, Ziegler A, Ngo ET, et al. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am J Med Genet 1999;87:23-9.[Medline]
  38. Whitehead AS, Gallagher P, Mills JL, et al. A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. QJM 1995;88:763-6.[Abstract/Free Full Text]
  39. Christensen B, Arbour L, Tran P, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 1999;84:151-7.[Medline]
  40. Shields DC, Kirke PN, Mills JL, et al. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 1999;64:1045-55[Medline]
  41. Hobbs CA, Sherman SL, Yi P, et al. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 2000;67:623-30.[Medline]
  42. Rosenblatt DS. Folate and homocysteine metabolism and gene polymorphisms in the etiology of Down syndrome. Am J Clin Nutr 1999;70:429-30.[Free Full Text]
  43. Hassold TJ, Burrage LC, Chan ER, et al. Maternal folate polymorphisms and the etiology of human nondisjunction. Am J Hum Genet 2001;69:434-9.[Medline]
  44. O'Leary VB, Parle-McDermott AP, Molloy AM, et al. MTRR and MTHFR polymorphisms: link to Down syndrome? Am J Med Genet 2002;107:151-5.[Medline]
  45. Stuppia L, Gatta V, Gaspari AR, et al. C677T mutation in the 5,10-MTHFR gene and risk of Down syndrome in Italy. Eur J Hum Genet 2002;10:388-90.[Medline]
  46. Chadefaux-Vekemans B, Coude M, Muller F, Oury J, Cali A, Kamoun P. Methylenetetrahydrofolate reductase polymorphisms in the etiology of Down syndrome. Pediatr Res 2002;51:766-7.[Medline]
  47. Boduroglu K, Alanay Y, Koldan B, Tuncbilek E. Methylenetetrahydrofolate reductase enzyme polymorphisms as maternal risk for Down syndrome among Turkish women. Am J Med Genet A 2004;127:5-10.[Medline]
  48. Zetterberg H, Regland B, Palmér M, et al. The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion. Hum Reprod 2002;17:3033-6.[Abstract/Free Full Text]
  49. Zetterberg H, Zafiropoulos A, Spandidos DA, Rymo L, Blennow K. Gene-gene interaction between fetal MTHFR 677C->T and transcobalamin 776C>G polymorphisms in human spontaneous abortion. Hum Reprod 2003;18:1948-50.[Abstract/Free Full Text]
  50. Namour F, Olivier J, Abdelmouttaleb I, et al. Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood. Blood 2001;97:1092-8.[Abstract/Free Full Text]
  51. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997;94:3290-5.[Abstract/Free Full Text]
  52. Kapiszewska M, Kalemba M, Wojciech U, Milewicz T. Uracil misincorporation into DNA of leukocytes of young women with positive folate balance depends on plasma vitamin B-12 concentrations and methylenetetrahydrofolate reductase polymorphisms. A pilot study. J Nutr Biochem 2005;8:467-78.
  53. Ingrosso D, Cimmino A, Perna AF, et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003;361:1693-9.[Medline]
  54. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Gen Metab 1998;64:169-72.[Medline]
  55. Weisberg IS, Jacques PF, Selhub J, et al. The 1298A->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001;156:409-15.[Medline]
  56. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, et al. Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia. Am J Obstet Gynecol 2001;184:394-402.[Medline]
  57. Aldamiz-Echevarria L, Sanjurjo P, Vallo A, et al. Hyperhomocysteinemia in children with renal transplants. Pediatr Nephrol 2002;17:718-23.[Medline]
  58. Akar N, Akar E, Ozel D, Deda G, Sipahi T. Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res 2001;102:115-20.[Medline]
  59. Guéant-Rodriguez RM, Juillière Y, Candito M, et al. Association of MTRR A66G polymorphism (but not of MTHFR C677T and A1298C, MTR A2756G, TCN C776G) with homocysteine and coronary artery disease in the French population. Thromb Haemost 2005;94:510-5.[Medline]
  60. Yamada K, Chen Z, Rozen R, Matthews RG. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci U S A 2001;26:14853-8.
Received for publication April 21, 2005. Accepted for publication November 23, 2005.




This article has been cited by other articles:


Home page
 Genome ResHome page
G. Jimenez-Sanchez, I. Silva-Zolezzi, A. Hidalgo, and S. March
Genomic medicine in Mexico: Initial steps and the road ahead
Genome Res., August 1, 2008; 18(8): 1191 - 1198.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
Q.-H. Yang, L. D Botto, M. Gallagher, J. Friedman, C. L Sanders, D. Koontz, S. Nikolova, J D. Erickson, and K. Steinberg
Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank
Am. J. Clinical Nutrition, July 1, 2008; 88(1): 232 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
S. Boccia, R. Hung, G. Ricciardi, F. Gianfagna, M. P. A. Ebert, J.-Y. Fang, C.-M. Gao, T. Gotze, F. Graziano, M. Lacasana-Navarro, et al.
Meta- and Pooled Analyses of the Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer Risk: A Huge-GSEC Review
Am. J. Epidemiol., March 1, 2008; 167(5): 505 - 516.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
J.-L. Gueant, N. W Chabi, R.-M. Gueant-Rodriguez, O. M Mutchinick, R. Debard, C. Payet, X. Lu, C. Villaume, J.-P. Bronowicki, E. V Quadros, et al.
Environmental influence on the worldwide prevalence of a 776C->G variant in the transcobalamin gene (TCN2)
J. Med. Genet., June 1, 2007; 44(6): 363 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
T. Forges, P. Monnier-Barbarino, J.M. Alberto, R.M. Gueant-Rodriguez, J.L. Daval, and J.L. Gueant
Impact of folate and homocysteine metabolism on human reproductive health
Hum. Reprod. Update, May 1, 2007; 13(3): 225 - 238.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
L. Cordain and M. S Hickey
Ultraviolet radiation represents an evolutionary selective pressure for the south-to-north gradient of the MTHFR 677TT genotype.
Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1243 - 1243.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J.-L. Gueant, R.-M. Gueant-Rodriguez, T. Forges, P. Barbarino, and F. Namour
Reply to L Cordain and MS Hickey
Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1244 - 1245.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guéant-Rodriguez, R.-M.
Right arrow Articles by Mutchinick, O. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guéant-Rodriguez, R.-M.
Right arrow Articles by Mutchinick, O. M
Agricola
Right arrow Articles by Guéant-Rodriguez, R.-M.
Right arrow Articles by Mutchinick, O. M

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS